AK156

· Asahi Kasei Therapeutics Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AK156, covering 2015-10-02 to 2015-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of AK156 in Primary Osteoporosis Patients [Phase 3]